Moore Capital Management LP Cuts Stock Position in Cigna Group $CI

Moore Capital Management LP trimmed its position in shares of Cigna Group (NYSE:CI - Free Report) by 28.3% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 71,134 shares of the health services provider's stock after selling 28,033 shares during the quarter. Moore Capital Management LP's holdings in Cigna Group were worth $19,610,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Two Sigma Securities LLC acquired a new stake in Cigna Group in the second quarter valued at approximately $4,398,000. Benjamin Edwards Inc. lifted its holdings in shares of Cigna Group by 20.8% during the 2nd quarter. Benjamin Edwards Inc. now owns 4,560 shares of the health services provider's stock valued at $1,257,000 after purchasing an additional 786 shares during the last quarter. Cookson Peirce & Co. Inc. lifted its holdings in shares of Cigna Group by 4.8% during the 2nd quarter. Cookson Peirce & Co. Inc. now owns 6,632 shares of the health services provider's stock valued at $1,828,000 after purchasing an additional 304 shares during the last quarter. Van Den Berg Management I Inc. boosted its position in shares of Cigna Group by 0.5% in the 2nd quarter. Van Den Berg Management I Inc. now owns 31,263 shares of the health services provider's stock worth $8,619,000 after purchasing an additional 151 shares in the last quarter. Finally, Wedbush Securities Inc. boosted its position in shares of Cigna Group by 12.0% in the 2nd quarter. Wedbush Securities Inc. now owns 4,330 shares of the health services provider's stock worth $1,194,000 after purchasing an additional 463 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company's stock.

Cigna Group Stock Performance

Shares of CI stock opened at $278.89 on Monday. The firm has a market capitalization of $73.69 billion, a price-to-earnings ratio of 11.54, a price-to-earnings-growth ratio of 0.96 and a beta of 0.29. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. The business has a fifty day moving average of $283.52 and a 200 day moving average of $281.30. Cigna Group has a 1 year low of $239.51 and a 1 year high of $315.47.

Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping analysts' consensus estimates of $7.60 by $0.18. The company had revenue of $70.04 billion during the quarter, compared to analysts' expectations of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The firm's revenue was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, research analysts expect that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group's payout ratio is 25.82%.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 2,677 shares of the firm's stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total transaction of $748,515.97. Following the completion of the transaction, the insider directly owned 25,880 shares of the company's stock, valued at approximately $7,236,306.80. This trade represents a 9.37% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares of the company's stock, valued at approximately $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 23,012 shares of company stock valued at $6,386,550 in the last ninety days. Corporate insiders own 0.60% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on CI shares. Jefferies Financial Group lowered Cigna Group from a "buy" rating to a "hold" rating and reduced their target price for the company from $336.00 to $307.00 in a research report on Tuesday, August 4th. Mizuho raised their price target on Cigna Group from $330.00 to $340.00 and gave the stock an "outperform" rating in a report on Monday, June 8th. Barclays boosted their price target on Cigna Group from $304.00 to $310.00 and gave the stock an "equal weight" rating in a research note on Friday, July 31st. Robert W. Baird set a $362.00 price objective on shares of Cigna Group in a research report on Friday, July 31st. Finally, Guggenheim lifted their target price on shares of Cigna Group from $338.00 to $361.00 and gave the stock a "buy" rating in a research note on Friday, July 31st. Fifteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Cigna Group has a consensus rating of "Moderate Buy" and an average price target of $339.45.

About Cigna Group

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source